Company Filing History:
Years Active: 2021
Title: Susanne Scheele: Innovator in GLP-1 Derivative Compositions
Introduction
Susanne Scheele is a prominent inventor based in Staffanstorp, Sweden. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative compositions for oral administration.
Latest Patents
Susanne holds a patent for "Solid GLP-1 derivative compositions for oral administration." This invention relates to solid compositions that include either a GLP-1 derivative combined with the SGLT2 inhibitor dapagliflozin or a GLP-1 derivative paired with a salt of NAC in conjunction with an SGLT2 inhibitor. This patent showcases her commitment to advancing therapeutic options for patients.
Career Highlights
Susanne Scheele is currently employed at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. Her work at Novo Nordisk has allowed her to focus on innovative solutions that improve patient outcomes.
Collaborations
Throughout her career, Susanne has collaborated with notable colleagues, including Andreas Vegge and Simon Bjerregaard. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion
Susanne Scheele's contributions to the field of pharmaceutical sciences, particularly through her patent on GLP-1 derivative compositions, highlight her role as an innovator. Her work at Novo Nordisk and collaborations with esteemed colleagues further emphasize her impact on advancing healthcare solutions.